BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 33641583)

  • 1. Comparing intravenous peramivir with oral oseltamivir for patients with influenza: a meta-analysis of randomized controlled trials.
    Fang YH; Hsu TH; Lin TY; Liu CH; Chou SC; Wu JY; Perng PC
    Expert Rev Anti Infect Ther; 2021 Aug; 19(8):1039-1046. PubMed ID: 33641583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of Efficacy of Intravenous Peramivir and Oral Oseltamivir for the Treatment of Influenza: Systematic Review and Meta-Analysis.
    Lee J; Park JH; Jwa H; Kim YH
    Yonsei Med J; 2017 Jul; 58(4):778-785. PubMed ID: 28540991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase III randomized, double-blind study comparing single-dose intravenous peramivir with oral oseltamivir in patients with seasonal influenza virus infection.
    Kohno S; Yen MY; Cheong HJ; Hirotsu N; Ishida T; Kadota J; Mizuguchi M; Kida H; Shimada J;
    Antimicrob Agents Chemother; 2011 Nov; 55(11):5267-76. PubMed ID: 21825298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Meta-Analysis Comparing the Efficacy and Safety of Peramivir with Other Neuraminidase Inhibitors for Influenza Treatment.
    Chen JY; Wei SK; Lai CC; Weng TS; Wang HH
    Medicina (Kaunas); 2020 Feb; 56(2):. PubMed ID: 32033501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous peramivir vs oral oseltamivir in high-risk emergency department patients with influenza: Results from a pilot randomized controlled study.
    Hsieh YH; Dugas AF; LoVecchio F; McBryde B; Ricketts EP; Saliba-Shaw K; Rothman RE
    Influenza Other Respir Viruses; 2021 Jan; 15(1):121-131. PubMed ID: 33006445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of respiratory symptoms and health-related quality of life with peramivir in influenza patients with chronic respiratory disease: Additional outcomes of a randomized, open-label study.
    Kato M; Saisho Y; Tanaka H; Bando T
    Influenza Other Respir Viruses; 2021 Sep; 15(5):651-660. PubMed ID: 33683019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peramivir is as effective as oral oseltamivir in the treatment of severe seasonal influenza.
    Yoo JW; Choi SH; Huh JW; Lim CM; Koh Y; Hong SB
    J Med Virol; 2015 Oct; 87(10):1649-55. PubMed ID: 25946636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A clinical trial of intravenous peramivir compared with oral oseltamivir for the treatment of seasonal influenza in hospitalized adults.
    Ison MG; Hui DS; Clezy K; O'Neil BJ; Flynt A; Collis PJ; Simon TJ; Alexander WJ
    Antivir Ther; 2013; 18(5):651-61. PubMed ID: 23111657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of pharmacokinetic interaction between intravenous peramivir and oral oseltamivir or rimantadine in humans.
    Atiee G; Lasseter K; Baughman S; McCullough A; Collis P; Hollister A; Hernandez J
    J Clin Pharmacol; 2012 Sep; 52(9):1410-9. PubMed ID: 21960669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical efficiency in children treated with intravenous drip infusion of peramivir].
    Sakata H
    Jpn J Antibiot; 2011 Dec; 64(6):383-7. PubMed ID: 22686008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of intravenous peramivir for treatment of severe influenza A(H1N1)pdm09.
    Louie JK; Yang S; Yen C; Acosta M; Schechter R; Uyeki TM
    PLoS One; 2012; 7(6):e40261. PubMed ID: 22768265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of peramivir on respiratory symptom improvement in patients with influenza virus infection and pre-existing chronic respiratory disease: Findings of a randomized, open-label study.
    Kato M; Saisho Y; Tanaka H; Bando T
    Influenza Other Respir Viruses; 2021 Jan; 15(1):132-141. PubMed ID: 32677375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience in adults and children treated with intravenous peramivir for 2009 influenza A (H1N1) under an Emergency IND program in the United States.
    Hernandez JE; Adiga R; Armstrong R; Bazan J; Bonilla H; Bradley J; Dretler R; Ison MG; Mangino JE; Maroushek S; Shetty AK; Wald A; Ziebold C; Elder J; Hollister AS; Sheridan W;
    Clin Infect Dis; 2011 Mar; 52(6):695-706. PubMed ID: 21367722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peramivir: A Review in Uncomplicated Influenza.
    Scott LJ
    Drugs; 2018 Sep; 78(13):1363-1370. PubMed ID: 30196350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oseltamivir treatment for influenza in adults: a meta-analysis of randomised controlled trials.
    Dobson J; Whitley RJ; Pocock S; Monto AS
    Lancet; 2015 May; 385(9979):1729-1737. PubMed ID: 25640810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical effectiveness of neuraminidase inhibitors--oseltamivir, zanamivir, laninamivir, and peramivir--for treatment of influenza A(H3N2) and A(H1N1)pdm09 infection: an observational study in the 2010-2011 influenza season in Japan.
    Shobugawa Y; Saito R; Sato I; Kawashima T; Dapat C; Dapat IC; Kondo H; Suzuki Y; Saito K; Suzuki H
    J Infect Chemother; 2012 Dec; 18(6):858-64. PubMed ID: 22644080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of intravenous peramivir, compared with oral oseltamivir, on the outcome of post-influenza pneumococcal pneumonia in mice.
    Tanaka A; Nakamura S; Seki M; Iwanaga N; Kajihara T; Kitano M; Homma T; Kurihara S; Imamura Y; Miyazaki T; Izumikawa K; Kakeya H; Yanagihara K; Kohno S
    Antivir Ther; 2015; 20(1):11-9. PubMed ID: 24517996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combinations of oseltamivir and peramivir for the treatment of influenza A (H1N1) virus infections in cell culture and in mice.
    Smee DF; Hurst BL; Wong MH; Tarbet EB; Babu YS; Klumpp K; Morrey JD
    Antiviral Res; 2010 Oct; 88(1):38-44. PubMed ID: 20633577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single dose peramivir for the treatment of acute seasonal influenza: integrated analysis of efficacy and safety from two placebo-controlled trials.
    Whitley R; Laughlin A; Carson S; Mitha E; Tellier G; Stich M; Elder J; Alexander WJ; Dobo S; Collis P; Sheridan WP
    Antivir Ther; 2015; 20(7):709-19. PubMed ID: 25318121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of peramivir for influenza treatment.
    Hata A; Akashi-Ueda R; Takamatsu K; Matsumura T
    Drug Des Devel Ther; 2014; 8():2017-38. PubMed ID: 25368514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.